Clinical Trial Update: SGLT2 Inhibition in Older Obese Adults With Pre-diabetes [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on SGLT2 inhibition in older obese adults with pre-diabetes across Phase 1 and Phase 2; results posted, completion status achieved.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aging
• Obesity
• Pre-diabetes

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Aging | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-01-05